Page last updated: 2024-10-27

flecainide and Diathesis

flecainide has been researched along with Diathesis in 3 studies

Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).

Research Excerpts

ExcerptRelevanceReference
"Phase-2 ventricular arrhythmias occur during infarct evolution."5.33Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts. ( Clements-Jewery, H; Curtis, MJ; Kabra, R; Kanaganayagam, GS, 2006)
"Phase-2 ventricular arrhythmias occur during infarct evolution."1.33Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts. ( Clements-Jewery, H; Curtis, MJ; Kabra, R; Kanaganayagam, GS, 2006)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clements-Jewery, H1
Kanaganayagam, GS1
Kabra, R1
Curtis, MJ1
Oltrona, L1
Broccolino, M1
Merlini, PA1
Spinola, A1
Pezzano, A1
Mannucci, PM1
Brugada, J1
Boersma, L1
Kirchhof, C1
Allessie, M1

Other Studies

3 other studies available for flecainide and Diathesis

ArticleYear
Actions of flecainide on susceptibility to phase-2 ventricular arrhythmias during infarct evolution in rat isolated perfused hearts.
    British journal of pharmacology, 2006, Volume: 147, Issue:5

    Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Susceptibility; Drug Design; Flecaini

2006
Activation of the hemostatic mechanism after pharmacological cardioversion of acute nonvalvular atrial fibrillation.
    Circulation, 1997, Apr-15, Volume: 95, Issue:8

    Topics: Acute Disease; Amiodarone; Anti-Arrhythmia Agents; Antithrombin III; Atrial Fibrillation; Biomarkers

1997
Increased susceptibility to reentrant arrhythmias by flecainide.
    Circulation, 1992, Volume: 85, Issue:1

    Topics: Arrhythmias, Cardiac; Disease Susceptibility; Flecainide; Humans

1992